Vir Biotechnology Inc
NASDAQ:VIR
Income Statement
Earnings Waterfall
Vir Biotechnology Inc
Revenue
|
86.2m
USD
|
Cost of Revenue
|
-2.8m
USD
|
Gross Profit
|
83.4m
USD
|
Operating Expenses
|
-767.7m
USD
|
Operating Income
|
-684.3m
USD
|
Other Expenses
|
69.2m
USD
|
Net Income
|
-615.1m
USD
|
Income Statement
Vir Biotechnology Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||
Revenue |
12
N/A
|
10
-13%
|
8
-21%
|
10
+25%
|
75
+644%
|
76
+1%
|
76
+1%
|
73
-5%
|
183
+152%
|
284
+56%
|
1 095
+285%
|
2 326
+112%
|
2 108
-9%
|
2 379
+13%
|
1 616
-32%
|
446
-72%
|
491
+10%
|
119
-76%
|
86
-27%
|
|
Gross Profit | ||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(9)
|
(66)
|
(156)
|
(183)
|
(197)
|
(146)
|
(58)
|
(30)
|
(8)
|
(3)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
178
+8 795%
|
274
+54%
|
1 030
+276%
|
2 170
+111%
|
1 925
-11%
|
2 182
+13%
|
1 470
-33%
|
388
-74%
|
461
+19%
|
111
-76%
|
83
-25%
|
|
Operating Income | ||||||||||||||||||||
Operating Expenses |
(139)
|
(151)
|
(186)
|
(229)
|
(287)
|
(328)
|
(373)
|
(456)
|
(475)
|
(535)
|
(609)
|
(577)
|
(619)
|
(627)
|
(636)
|
(712)
|
(775)
|
(807)
|
(768)
|
|
Selling, General & Administrative |
(32)
|
(34)
|
(38)
|
(42)
|
(50)
|
(60)
|
(71)
|
(84)
|
(96)
|
(128)
|
(161)
|
(173)
|
(186)
|
(179)
|
(162)
|
(170)
|
(176)
|
(174)
|
(178)
|
|
Research & Development |
(108)
|
(118)
|
(147)
|
(188)
|
(238)
|
(268)
|
(301)
|
(372)
|
(379)
|
(407)
|
(448)
|
(403)
|
(432)
|
(448)
|
(474)
|
(542)
|
(599)
|
(633)
|
(589)
|
|
Depreciation & Amortization |
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
|
Operating Income |
(128)
N/A
|
(141)
-10%
|
(178)
-26%
|
(219)
-23%
|
(213)
+3%
|
(252)
-19%
|
(297)
-18%
|
(384)
-29%
|
(294)
+23%
|
(259)
+12%
|
421
N/A
|
1 593
+279%
|
1 307
-18%
|
1 555
+19%
|
833
-46%
|
(324)
N/A
|
(314)
+3%
|
(696)
-122%
|
(684)
+2%
|
|
Pre-Tax Income | ||||||||||||||||||||
Interest Income Expense |
6
|
7
|
9
|
8
|
7
|
5
|
3
|
2
|
1
|
165
|
139
|
44
|
34
|
(134)
|
(83)
|
20
|
47
|
70
|
65
|
|
Total Other Income |
(1)
|
(3)
|
(5)
|
(12)
|
(15)
|
(9)
|
(5)
|
(8)
|
(4)
|
(7)
|
(9)
|
4
|
4
|
30
|
4
|
(7)
|
(8)
|
(34)
|
(9)
|
|
Pre-Tax Income |
(123)
N/A
|
(137)
-12%
|
(175)
-27%
|
(223)
-28%
|
(220)
+1%
|
(257)
-16%
|
(299)
-16%
|
(390)
-31%
|
(297)
+24%
|
(102)
+66%
|
550
N/A
|
1 641
+198%
|
1 345
-18%
|
1 452
+8%
|
754
-48%
|
(311)
N/A
|
(275)
+12%
|
(659)
-140%
|
(628)
+5%
|
|
Net Income | ||||||||||||||||||||
Tax Provision |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(21)
|
(424)
|
(267)
|
(309)
|
(238)
|
167
|
13
|
58
|
13
|
|
Income from Continuing Operations |
(123)
|
(137)
|
(175)
|
(223)
|
(221)
|
(257)
|
(299)
|
(390)
|
(297)
|
(102)
|
529
|
1 216
|
1 078
|
1 143
|
516
|
(144)
|
(262)
|
(601)
|
(615)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(123)
N/A
|
(137)
-12%
|
(175)
-27%
|
(223)
-28%
|
(221)
+1%
|
(257)
-16%
|
(299)
-16%
|
(390)
-31%
|
(297)
+24%
|
(102)
+66%
|
529
N/A
|
1 216
+130%
|
1 078
-11%
|
1 143
+6%
|
516
-55%
|
(144)
N/A
|
(262)
-82%
|
(601)
-129%
|
(615)
-2%
|
|
EPS (Diluted) |
-1.12
N/A
|
-1.25
-12%
|
-5.76
-361%
|
-2.05
+64%
|
-1.91
+7%
|
-2.04
-7%
|
-2.51
-23%
|
-3.01
-20%
|
-2.22
+26%
|
-0.76
+66%
|
3.96
N/A
|
9.06
+129%
|
8.13
-10%
|
8.46
+4%
|
3.83
-55%
|
-1.07
N/A
|
-1.97
-84%
|
-4.49
-128%
|
-4.59
-2%
|